| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucose | 23 | 2018 | 164 | 3.980 |
Why?
|
| Insulin Resistance | 17 | 2018 | 449 | 3.600 |
Why?
|
| Iron | 12 | 2019 | 113 | 3.370 |
Why?
|
| Adipocytes | 9 | 2019 | 79 | 2.940 |
Why?
|
| Hemochromatosis | 9 | 2015 | 70 | 2.920 |
Why?
|
| Liver | 11 | 2016 | 464 | 1.940 |
Why?
|
| Hexosamines | 7 | 2010 | 8 | 1.870 |
Why?
|
| Insulin | 18 | 2018 | 346 | 1.810 |
Why?
|
| Mice | 42 | 2019 | 2372 | 1.750 |
Why?
|
| Insulin-Secreting Cells | 6 | 2013 | 53 | 1.660 |
Why?
|
| Acetylglucosamine | 5 | 2011 | 5 | 1.610 |
Why?
|
| Leptin | 5 | 2019 | 66 | 1.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2015 | 1383 | 1.470 |
Why?
|
| Adipose Tissue | 8 | 2018 | 327 | 1.450 |
Why?
|
| Iron, Dietary | 4 | 2014 | 11 | 1.440 |
Why?
|
| Muscle, Skeletal | 15 | 2018 | 494 | 1.280 |
Why?
|
| Iron Overload | 3 | 2013 | 37 | 1.270 |
Why?
|
| N-Acetylglucosaminyltransferases | 4 | 2008 | 6 | 1.210 |
Why?
|
| Animals | 44 | 2019 | 7302 | 1.190 |
Why?
|
| Mice, Inbred C57BL | 19 | 2016 | 711 | 1.170 |
Why?
|
| Altitude | 4 | 2015 | 6 | 1.100 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 72 | 1.050 |
Why?
|
| Blood Glucose | 9 | 2018 | 467 | 1.040 |
Why?
|
| Models, Biological | 2 | 2019 | 373 | 0.960 |
Why?
|
| Signal Transduction | 9 | 2012 | 667 | 0.960 |
Why?
|
| Dietary Supplements | 4 | 2015 | 170 | 0.950 |
Why?
|
| Homeostasis | 3 | 2015 | 127 | 0.900 |
Why?
|
| Oxygen | 3 | 2015 | 139 | 0.890 |
Why?
|
| Ferritins | 4 | 2018 | 46 | 0.880 |
Why?
|
| Gluconeogenesis | 4 | 2016 | 5 | 0.860 |
Why?
|
| Diabetes Mellitus | 4 | 2014 | 370 | 0.860 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2019 | 18 | 0.820 |
Why?
|
| Mice, Transgenic | 15 | 2013 | 249 | 0.780 |
Why?
|
| Adaptation, Physiological | 4 | 2015 | 51 | 0.770 |
Why?
|
| Manganese | 2 | 2013 | 10 | 0.770 |
Why?
|
| Muscle Proteins | 6 | 2014 | 57 | 0.750 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2014 | 19 | 0.730 |
Why?
|
| Circadian Rhythm | 3 | 2014 | 43 | 0.690 |
Why?
|
| Down-Regulation | 2 | 2019 | 143 | 0.680 |
Why?
|
| Transferrin | 1 | 2018 | 32 | 0.670 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2013 | 52 | 0.640 |
Why?
|
| Glycogen Synthase | 4 | 2008 | 4 | 0.640 |
Why?
|
| Energy Metabolism | 4 | 2015 | 139 | 0.630 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 481 | 0.630 |
Why?
|
| Humans | 38 | 2018 | 29220 | 0.610 |
Why?
|
| Glucose Intolerance | 5 | 2015 | 44 | 0.610 |
Why?
|
| Fatty Acids | 5 | 2015 | 93 | 0.610 |
Why?
|
| Adiponectin | 4 | 2013 | 103 | 0.610 |
Why?
|
| Male | 28 | 2018 | 17876 | 0.590 |
Why?
|
| Phlebotomy | 2 | 2014 | 17 | 0.590 |
Why?
|
| Protein-Serine-Threonine Kinases | 5 | 2013 | 44 | 0.590 |
Why?
|
| Obesity | 6 | 2014 | 1068 | 0.560 |
Why?
|
| Acclimatization | 2 | 2014 | 4 | 0.560 |
Why?
|
| Hyperglycemia | 3 | 2018 | 82 | 0.540 |
Why?
|
| Asian Continental Ancestry Group | 2 | 2014 | 110 | 0.540 |
Why?
|
| Eating | 2 | 2015 | 73 | 0.540 |
Why?
|
| Glycosylation | 6 | 2019 | 15 | 0.520 |
Why?
|
| Heme | 1 | 2014 | 60 | 0.490 |
Why?
|
| 3T3-L1 Cells | 4 | 2019 | 11 | 0.490 |
Why?
|
| Polycythemia | 2 | 2014 | 2 | 0.480 |
Why?
|
| Female | 24 | 2018 | 18241 | 0.470 |
Why?
|
| Histocompatibility Antigens Class I | 5 | 2014 | 58 | 0.470 |
Why?
|
| Mice, Knockout | 11 | 2015 | 425 | 0.460 |
Why?
|
| Dietary Fats | 4 | 2012 | 108 | 0.460 |
Why?
|
| Cooperative Behavior | 2 | 2012 | 73 | 0.450 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2012 | 12 | 0.440 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 22 | 0.440 |
Why?
|
| Membrane Proteins | 6 | 2014 | 256 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2009 | 69 | 0.430 |
Why?
|
| Phosphorylation | 8 | 2014 | 225 | 0.410 |
Why?
|
| Muscle Strength | 2 | 2011 | 139 | 0.410 |
Why?
|
| Lipid Metabolism | 4 | 2013 | 100 | 0.400 |
Why?
|
| Food | 2 | 2008 | 41 | 0.390 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 248 | 0.380 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 106 | 0.380 |
Why?
|
| Iron Chelating Agents | 1 | 2010 | 8 | 0.370 |
Why?
|
| Glucose Tolerance Test | 5 | 2018 | 125 | 0.360 |
Why?
|
| Disease Models, Animal | 7 | 2010 | 981 | 0.350 |
Why?
|
| Cell Line | 4 | 2018 | 450 | 0.350 |
Why?
|
| Athletic Performance | 1 | 2009 | 10 | 0.340 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2018 | 1079 | 0.340 |
Why?
|
| PPAR alpha | 3 | 2015 | 29 | 0.340 |
Why?
|
| Oligosaccharides | 1 | 2008 | 4 | 0.340 |
Why?
|
| Oncogene Protein v-akt | 1 | 2008 | 4 | 0.340 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2015 | 39 | 0.330 |
Why?
|
| RNA, Messenger | 5 | 2014 | 514 | 0.330 |
Why?
|
| Middle Aged | 12 | 2018 | 10872 | 0.330 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 2004 | 6 | 0.330 |
Why?
|
| Mitochondria, Liver | 1 | 2008 | 7 | 0.320 |
Why?
|
| Resistance Training | 1 | 2009 | 70 | 0.320 |
Why?
|
| Menopause | 1 | 2009 | 86 | 0.320 |
Why?
|
| Phosphotransferases (Phosphate Group Acceptor) | 1 | 2007 | 2 | 0.320 |
Why?
|
| Genotype | 3 | 2014 | 735 | 0.310 |
Why?
|
| Glucosamine | 3 | 2019 | 7 | 0.310 |
Why?
|
| Adult | 10 | 2018 | 8468 | 0.310 |
Why?
|
| Cells, Cultured | 6 | 2012 | 800 | 0.310 |
Why?
|
| Islets of Langerhans | 3 | 2007 | 75 | 0.310 |
Why?
|
| Parathyroidectomy | 1 | 2007 | 10 | 0.310 |
Why?
|
| Endothelial Cells | 2 | 2009 | 179 | 0.310 |
Why?
|
| Parathyroid Neoplasms | 1 | 2007 | 7 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 212 | 0.300 |
Why?
|
| Proteins | 2 | 2010 | 140 | 0.300 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 81 | 0.300 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 8 | 0.300 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2007 | 50 | 0.300 |
Why?
|
| Adenoma | 1 | 2007 | 35 | 0.300 |
Why?
|
| Diabetic Angiopathies | 1 | 2008 | 137 | 0.300 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 51 | 0.300 |
Why?
|
| Transcription Factors | 5 | 2014 | 172 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1019 | 0.280 |
Why?
|
| Mitochondria, Muscle | 3 | 2012 | 17 | 0.280 |
Why?
|
| Oxidative Stress | 4 | 2013 | 223 | 0.270 |
Why?
|
| Tibet | 3 | 2015 | 3 | 0.270 |
Why?
|
| Enzyme Activation | 4 | 2013 | 126 | 0.260 |
Why?
|
| Oxygen Consumption | 3 | 2010 | 138 | 0.250 |
Why?
|
| Gene Expression | 5 | 2014 | 332 | 0.250 |
Why?
|
| Forkhead Transcription Factors | 3 | 2014 | 26 | 0.250 |
Why?
|
| Aging | 1 | 2011 | 881 | 0.250 |
Why?
|
| Streptozocin | 1 | 2004 | 8 | 0.250 |
Why?
|
| Oxidation-Reduction | 6 | 2018 | 250 | 0.230 |
Why?
|
| Haplotypes | 2 | 2015 | 220 | 0.230 |
Why?
|
| Alleles | 2 | 2015 | 251 | 0.230 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 100 | 0.230 |
Why?
|
| Receptor, Insulin | 3 | 2009 | 9 | 0.220 |
Why?
|
| Gene Deletion | 3 | 2012 | 64 | 0.220 |
Why?
|
| Uridine Diphosphate N-Acetylglucosamine | 1 | 2002 | 1 | 0.220 |
Why?
|
| Superoxide Dismutase | 3 | 2013 | 47 | 0.220 |
Why?
|
| Apoptosis | 1 | 2004 | 337 | 0.220 |
Why?
|
| Myocardium | 3 | 2013 | 170 | 0.210 |
Why?
|
| Procollagen-Proline Dioxygenase | 2 | 2012 | 2 | 0.210 |
Why?
|
| Mitochondria, Heart | 2 | 2013 | 17 | 0.210 |
Why?
|
| Pyruvate Dehydrogenase Complex | 2 | 2012 | 13 | 0.210 |
Why?
|
| Up-Regulation | 1 | 2002 | 183 | 0.210 |
Why?
|
| Mutation | 2 | 2015 | 466 | 0.200 |
Why?
|
| Prevalence | 2 | 2014 | 907 | 0.200 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 320 | 0.190 |
Why?
|
| Lipid Peroxidation | 2 | 2013 | 34 | 0.190 |
Why?
|
| Trans-Activators | 2 | 2013 | 47 | 0.190 |
Why?
|
| Overweight | 2 | 2015 | 259 | 0.190 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 3 | 2004 | 3 | 0.180 |
Why?
|
| Triglycerides | 5 | 2015 | 214 | 0.180 |
Why?
|
| Reactive Oxygen Species | 3 | 2014 | 159 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2018 | 1695 | 0.170 |
Why?
|
| Phenotype | 3 | 2015 | 629 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 73 | 0.170 |
Why?
|
| Blood Pressure | 3 | 2013 | 807 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 109 | 0.160 |
Why?
|
| Selection, Genetic | 2 | 2015 | 11 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2009 | 10 | 0.160 |
Why?
|
| Young Adult | 4 | 2018 | 2413 | 0.160 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2017 | 20 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 681 | 0.160 |
Why?
|
| Time Factors | 4 | 2012 | 2003 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 14 | 0.150 |
Why?
|
| Risk Factors | 3 | 2014 | 3550 | 0.140 |
Why?
|
| Pyruvic Acid | 1 | 2016 | 5 | 0.140 |
Why?
|
| Adenosine Triphosphate | 2 | 2013 | 52 | 0.140 |
Why?
|
| Hypoglycemia | 1 | 2016 | 41 | 0.140 |
Why?
|
| Response Elements | 1 | 2015 | 16 | 0.140 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 51 | 0.130 |
Why?
|
| Ceramides | 1 | 2015 | 9 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 3 | 2004 | 9 | 0.130 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Myositis | 1 | 2015 | 10 | 0.130 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 16 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2013 | 281 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2015 | 52 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 39 | 0.130 |
Why?
|
| Motor Activity | 2 | 2015 | 311 | 0.130 |
Why?
|
| Aminolevulinic Acid | 1 | 2014 | 6 | 0.130 |
Why?
|
| Cold Temperature | 1 | 2015 | 39 | 0.130 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 23 | 0.130 |
Why?
|
| Acetylcysteine | 1 | 2014 | 11 | 0.130 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 1 | 0.130 |
Why?
|
| Leucine-tRNA Ligase | 1 | 2014 | 1 | 0.130 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 61 | 0.130 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2014 | 6 | 0.130 |
Why?
|
| Guanosine Triphosphate | 1 | 2014 | 8 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 401 | 0.120 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 31 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 46 | 0.120 |
Why?
|
| Mice, Obese | 2 | 2012 | 22 | 0.120 |
Why?
|
| Rats | 4 | 2011 | 1604 | 0.120 |
Why?
|
| European Continental Ancestry Group | 1 | 2018 | 1131 | 0.120 |
Why?
|
| DNA Primers | 2 | 2011 | 87 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 32 | 0.120 |
Why?
|
| African Americans | 2 | 2018 | 1373 | 0.120 |
Why?
|
| Antioxidants | 1 | 2014 | 114 | 0.120 |
Why?
|
| Research Support as Topic | 2 | 2012 | 25 | 0.120 |
Why?
|
| Frail Elderly | 1 | 2014 | 65 | 0.120 |
Why?
|
| Mitochondria | 2 | 2012 | 174 | 0.120 |
Why?
|
| Acetylation | 1 | 2013 | 13 | 0.110 |
Why?
|
| Adenosine Monophosphate | 1 | 2013 | 6 | 0.110 |
Why?
|
| Sarcopenia | 1 | 2014 | 53 | 0.110 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2012 | 2 | 0.110 |
Why?
|
| Weight Gain | 2 | 2012 | 109 | 0.110 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Utah | 1 | 2012 | 15 | 0.110 |
Why?
|
| Myoblasts | 1 | 2013 | 38 | 0.110 |
Why?
|
| Iron-Binding Proteins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Homozygote | 1 | 2012 | 57 | 0.110 |
Why?
|
| Ethnic Groups | 1 | 2015 | 440 | 0.110 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 24 | 0.110 |
Why?
|
| PPAR gamma | 1 | 2012 | 45 | 0.110 |
Why?
|
| Hypertension, Renal | 1 | 2012 | 29 | 0.110 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2012 | 29 | 0.110 |
Why?
|
| Mass Screening | 1 | 2014 | 225 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 148 | 0.100 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2011 | 1 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2012 | 478 | 0.100 |
Why?
|
| Glycolysis | 3 | 2009 | 19 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2014 | 867 | 0.100 |
Why?
|
| Cyclophilins | 1 | 2010 | 2 | 0.100 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 4 | 0.100 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 182 | 0.100 |
Why?
|
| Heart | 3 | 2013 | 162 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2013 | 436 | 0.100 |
Why?
|
| Diet | 1 | 2013 | 356 | 0.100 |
Why?
|
| Liver Glycogen | 1 | 2010 | 4 | 0.090 |
Why?
|
| Calorimetry, Indirect | 1 | 2010 | 3 | 0.090 |
Why?
|
| Thermogenesis | 1 | 2010 | 4 | 0.090 |
Why?
|
| Awards and Prizes | 1 | 2010 | 11 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 836 | 0.090 |
Why?
|
| RNA | 1 | 2010 | 88 | 0.090 |
Why?
|
| Regression Analysis | 1 | 2010 | 274 | 0.090 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2009 | 1 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 37 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2008 | 31 | 0.090 |
Why?
|
| Aged | 5 | 2017 | 9515 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2008 | 30 | 0.080 |
Why?
|
| Legislation, Food | 1 | 2008 | 1 | 0.080 |
Why?
|
| Glycomics | 1 | 2008 | 1 | 0.080 |
Why?
|
| Wheat Germ Agglutinins | 1 | 2008 | 1 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 48 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 129 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 71 | 0.080 |
Why?
|
| Drug Industry | 1 | 2008 | 14 | 0.080 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 44 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2008 | 61 | 0.080 |
Why?
|
| Aconitate Hydratase | 1 | 2008 | 1 | 0.080 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2008 | 1 | 0.080 |
Why?
|
| Electron Transport Complex IV | 1 | 2008 | 2 | 0.080 |
Why?
|
| Succinate Dehydrogenase | 1 | 2008 | 3 | 0.080 |
Why?
|
| Exercise Test | 1 | 2009 | 194 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 145 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 120 | 0.080 |
Why?
|
| Mitochondrial Proteins | 3 | 2014 | 67 | 0.080 |
Why?
|
| Capillaries | 1 | 2008 | 23 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2008 | 118 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2008 | 105 | 0.080 |
Why?
|
| Glycogen | 1 | 2007 | 3 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 40 | 0.080 |
Why?
|
| Thyroid Nodule | 1 | 2007 | 5 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2009 | 159 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2009 | 149 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2008 | 72 | 0.080 |
Why?
|
| Parathyroid Hormone | 1 | 2007 | 40 | 0.080 |
Why?
|
| Organ Size | 2 | 2004 | 196 | 0.070 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 21 | 0.070 |
Why?
|
| Cell Movement | 1 | 2008 | 161 | 0.070 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 50 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2008 | 154 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2007 | 110 | 0.070 |
Why?
|
| Lipids | 1 | 2007 | 211 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 466 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2007 | 171 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 533 | 0.070 |
Why?
|
| Exercise | 1 | 2011 | 595 | 0.070 |
Why?
|
| Phosphofructokinase-2 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Adolescent | 2 | 2015 | 3265 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2004 | 30 | 0.060 |
Why?
|
| Epididymis | 1 | 2004 | 9 | 0.060 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2003 | 3 | 0.060 |
Why?
|
| Deoxyglucose | 1 | 2003 | 16 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 87 | 0.060 |
Why?
|
| United States | 2 | 2012 | 3648 | 0.060 |
Why?
|
| Fasting | 1 | 2003 | 93 | 0.060 |
Why?
|
| 3T3 Cells | 1 | 2003 | 13 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cytosol | 1 | 2002 | 25 | 0.050 |
Why?
|
| Neoplasms | 1 | 2009 | 612 | 0.050 |
Why?
|
| Ventricular Myosins | 1 | 2002 | 1 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2004 | 573 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 97 | 0.050 |
Why?
|
| Hypertension | 1 | 2009 | 913 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2007 | 700 | 0.050 |
Why?
|
| Metabolome | 2 | 2013 | 31 | 0.050 |
Why?
|
| Age Factors | 1 | 2004 | 1110 | 0.050 |
Why?
|
| Child | 1 | 2007 | 2221 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 90 | 0.040 |
Why?
|
| Palmitic Acid | 2 | 2009 | 11 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 12 | 0.040 |
Why?
|
| Etoposide | 1 | 2017 | 30 | 0.040 |
Why?
|
| Vincristine | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 25 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 162 | 0.040 |
Why?
|
| Prednisone | 1 | 2017 | 43 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2017 | 55 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 3728 | 0.040 |
Why?
|
| Bed Rest | 1 | 2015 | 2 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2015 | 42 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 20 | 0.030 |
Why?
|
| Lagomorpha | 1 | 2015 | 1 | 0.030 |
Why?
|
| Rest | 1 | 2015 | 49 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2014 | 6 | 0.030 |
Why?
|
| Leucine | 1 | 2014 | 24 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 16 | 0.030 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2014 | 2 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2014 | 3 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 7 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Reference Values | 1 | 2014 | 224 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cholesterol | 1 | 2015 | 230 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 67 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 572 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2013 | 33 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 28 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 543 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 16 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 5 | 0.030 |
Why?
|
| Prostaglandin D2 | 1 | 2012 | 4 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2012 | 17 | 0.030 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2012 | 20 | 0.030 |
Why?
|
| Diglycerides | 1 | 2012 | 5 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 136 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2012 | 11 | 0.030 |
Why?
|
| Ion Channels | 1 | 2012 | 24 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2012 | 39 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2012 | 20 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2012 | 29 | 0.030 |
Why?
|
| Renin | 1 | 2012 | 112 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 508 | 0.030 |
Why?
|
| Arizona | 1 | 2011 | 7 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2011 | 10 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 638 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 365 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 80 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 57 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 788 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 61 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3122 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1366 | 0.020 |
Why?
|
| Photoperiod | 1 | 2009 | 3 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 37 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Hyperphagia | 1 | 2009 | 2 | 0.020 |
Why?
|
| alpha-MSH | 1 | 2009 | 2 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Corticosterone | 1 | 2009 | 9 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2009 | 18 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 30 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2009 | 40 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 54 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 44 | 0.020 |
Why?
|
| Amino Acids | 1 | 2009 | 41 | 0.020 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2008 | 1 | 0.020 |
Why?
|
| Triazenes | 1 | 2008 | 4 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2008 | 5 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 9 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 2008 | 2 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 454 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 62 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 10 | 0.020 |
Why?
|
| Vasodilation | 1 | 2009 | 87 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 36 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 36 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 116 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 103 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2008 | 60 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 290 | 0.020 |
Why?
|
| Phosphorylase Kinase | 1 | 2007 | 1 | 0.020 |
Why?
|
| Glycogen Phosphorylase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Apolipoprotein A-II | 1 | 2007 | 6 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 641 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 177 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2007 | 64 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 162 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 55 | 0.020 |
Why?
|
| Collagen | 1 | 2004 | 217 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2002 | 9 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2002 | 7 | 0.010 |
Why?
|